07:00 - 08:15 | 509 | CC7 How to deal with large airways problems | Challenging clinical cases |
07:00 - 08:15 | 510 | CC8 Complex management issues in ataxia telangiectasia | Challenging clinical cases |
07:00 - 08:15 | 511 | CC6 New treatment approaches in non-small cell lung cancer | Challenging clinical cases |
08:00 - 10:30 | 515 | PD7 Designing and conducting research in malignant pleural effusion | Professional development workshop |
08:00 - 10:20 | 516 | SW17 Polysomnography in adults and children | Skills workshop |
08:00 - 10:20 | 517 | SW16 Radiological-pathological correlations for clinicians | Skills workshop |
08:30 - 10:30 | 518 | Clinical year in review | Year in review |
08:30 - 10:30 | 519 | The problem of multidrug-resistant tuberculosis | Symposium |
08:30 - 10:30 | 520 | Obesity and respiratory diseases | Hot topics |
08:30 - 10:30 | 521 | Urban air pollution and human health | Symposium |
08:30 - 10:30 | 522 | Dysfunctional mitochondria in respiratory disease | Symposium |
08:30 - 10:30 | 523 | Cell therapy for ARDS and sepsis | Symposium |
08:30 - 10:30 | 524 | Presentation and discussion of a draft Lancet Commission on Asthma | Session |
08:30 - 10:30 | 525 | What can respiratory medicine learn from cystic fibrosis research? | Hot topics |
08:30 - 10:30 | 526 | Early determinants of childhood asthma and allergy | Oral Presentation |
08:30 - 10:30 | 527 | Novel insights into the treatment of COPD | Oral Presentation |
08:30 - 10:30 | 528 | Predictors of asthma among children and adults | Oral Presentation |
08:30 - 10:30 | 529 | Community-acquired pneumonia: update on prognostic factors and therapeutic strategies | Oral Presentation |
08:30 - 10:30 | 530 | Lung allograft dysfunction: insights into inflammatory/immune mechanisms | Oral Presentation |
08:30 - 10:30 | 531 | Therapeutic trials in lung cancer | Oral Presentation |
08:30 - 10:30 | 532 | Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques | Poster Discussion |
08:30 - 10:30 | 533 | Asthma points to ponder | Poster Discussion |
08:30 - 10:30 | 534 | Malignant pleural disease: diagnosis and management | Poster Discussion |
08:30 - 10:30 | 535 | How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease | Poster Discussion |
08:30 - 10:30 | 536 | Treatment options for obstructive sleep apnoea and obesity hypoventilation | Poster Discussion |
08:30 - 10:30 | 537 | Exploring mechanisms in health and disease | Poster Discussion |
10:40 - 13:00 | 548 | SW19 Polysomnography in adults and children | Skills workshop |
10:40 - 13:00 | 549 | SW18 Radiological-pathological correlations for clinicians | Skills workshop |
10:45 - 12:45 | 550 | Pulmonary endoscopy 2016 | Year in review |
10:45 - 12:45 | 551 | The management of acute exacerbations of COPD | Symposium |
10:45 - 12:45 | 552 | Oligometastasis: postmodern multimodality concepts | Symposium |
10:45 - 12:45 | 553 | Endotyping: the means to personalised medicine in lung disease | Symposium |
10:45 - 12:45 | 554 | Childhood wheeze: are we making any progress? | Symposium |
10:45 - 12:45 | 555 | Microbiome in health and in disease | Symposium |
10:45 - 12:45 | 556 | Hypoxia, the carotid body, and the brain | Symposium |
10:45 - 12:45 | 557 | The future is now: the challenge of ageing in respiratory medicine | Hot topics |
10:45 - 12:45 | 558 | New approaches and finding in smoking cessation | Oral Presentation |
10:45 - 12:45 | 559 | From microimaging to functional evaluation of the lung | Oral Presentation |
10:45 - 12:45 | 560 | Drug-resistant tuberculosis and experiences with delamanid and bedaquiline | Oral Presentation |
10:45 - 12:45 | 561 | Non-inflammatory COPD monitoring | Oral Presentation |
10:45 - 12:45 | 562 | How to choose the best strategy with noninvasive ventilation? | Oral Presentation |
10:45 - 12:45 | 563 | Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease | Oral Presentation |
10:45 - 12:45 | 564 | Epidemiological and clinical data regarding the modern management of chronic lung diseases | Poster Discussion |
10:45 - 12:45 | 565 | Diagnostic and therapeutic challenges in acute respiratory failure | Poster Discussion |
10:45 - 12:45 | 566 | New insights into pulmonary rehabilitation for chronic lung diseases | Poster Discussion |
10:45 - 12:45 | 567 | Pulmonary hypertension and chronic thromboembolic pulmonary hypertension | Poster Discussion |
10:45 - 12:45 | 568 | Man versus machine: waves, frequency, and more in lung function | Poster Discussion |
10:45 - 12:45 | 569 | Immune responses in the lung | Poster Discussion |
11:00 - 12:30 | 572 | PD8 Navigate your publishing process | Professional development workshop |
12:50 - 14:40 | 578 | Biomarkers and phenotypes of COPD | Thematic Poster |
12:50 - 14:40 | 579 | COPD diagnosis and management | Thematic Poster |
12:50 - 14:40 | 580 | Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases | Thematic Poster |
12:50 - 14:40 | 581 | The best clinical approach to lung diseases | Thematic Poster |
12:50 - 14:40 | 582 | Latest insights into the management of chronic respiratory diseases | Thematic Poster |
12:50 - 14:40 | 583 | Latest insights into chronic care | Thematic Poster |
12:50 - 14:40 | 584 | Hospitalisation and comorbidities in chronic lung diseases | Thematic Poster |
12:50 - 14:40 | 585 | A view into a chest and pleural pathology | Thematic Poster |
12:50 - 14:40 | 586 | Mixed-up imaging of various chest diseases | Thematic Poster |
12:50 - 14:40 | 587 | Airway stenting and ablation | Thematic Poster |
12:50 - 14:40 | 588 | EBUS and transthoracic ultrasound | Thematic Poster |
12:50 - 14:40 | 589 | Orphan diseases I | Thematic Poster |
12:50 - 14:40 | 590 | ILD: from the bench to the bedside | Thematic Poster |
12:50 - 14:40 | 591 | Orphan diseases II | Thematic Poster |
12:50 - 14:40 | 592 | Screening, diagnosis, assessment, and treatment of COPD in primary care | Thematic Poster |
12:50 - 14:40 | 593 | Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care | Thematic Poster |
12:50 - 14:40 | 594 | Airway response to infection | Thematic Poster |
12:50 - 14:40 | 595 | Studies in airway cell biology | Thematic Poster |
12:50 - 14:40 | 596 | New signalling pathways in COPD | Thematic Poster |
12:50 - 14:40 | 597 | Common mechanisms in lung development and fibrosis | Thematic Poster |
12:50 - 14:40 | 598 | Novel avenues in the treatment of COPD I | Thematic Poster |
12:50 - 14:40 | 599 | Novel avenues in the treatment of COPD II | Thematic Poster |
12:50 - 14:40 | 600 | Preclinical pharmacology: drug targets and mechanisms of action | Thematic Poster |
12:50 - 14:40 | 601 | Asthma management | Thematic Poster |
12:50 - 14:40 | 602 | Functional assessment of the airways | Thematic Poster |
12:50 - 14:40 | 603 | Monitoring comorbidities | Thematic Poster |
12:50 - 14:40 | 604 | Phenotyping and monitoring airway diseases | Thematic Poster |
12:50 - 14:40 | 605 | Clinical studies in asthma and immunology | Thematic Poster |
12:50 - 14:40 | 606 | Asthma: treatment, disease control, and quality of life | Thematic Poster |
12:50 - 14:40 | 607 | Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing | Thematic Poster |
12:50 - 14:40 | 608 | Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease | Thematic Poster |
12:50 - 14:40 | 609 | Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods | Thematic Poster |
12:50 - 14:40 | 610 | The indoor and ambient environments | Thematic Poster |
12:50 - 14:40 | 611 | Smoking cessation strategies | Thematic Poster |
12:50 - 14:40 | 612 | Smoking-related diseases | Thematic Poster |
12:50 - 14:40 | 613 | Latest advances in paediatric sleep medicine | Thematic Poster |
12:50 - 14:40 | 614 | Techniques and tools in paediatric asthma | Thematic Poster |
12:50 - 14:40 | 615 | Living with asthma around the globe | Thematic Poster |
12:50 - 14:40 | 616 | The future of lung function is beginning now | Thematic Poster |
12:50 - 14:40 | 617 | Physiotherapy interventions and assessment options in hospitalised patients | Thematic Poster |
12:50 - 14:40 | 618 | Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy | Thematic Poster |
13:00 - 14:30 | 619 | Early life origins of asthma and COPD | Lunchtime session |
13:00 - 14:30 | 620 | Should we start screening programmes in Europe? | Lunchtime session |
13:00 - 14:30 | 621 | GOLD: novel approaches to COPD assessment and management | Lunchtime session |
13:00 - 14:30 | 622 | Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer? | Lunchtime session |
13:00 - 14:30 | 624 | Recertification of respiratory professionals: current practice and the future | Educational forum |
13:00 - 14:00 | 626 | ME12 Endoscopic lung volume reduction | Meet the expert |
13:00 - 14:00 | 627 | ME9 Detecting and correcting patient-ventilator asynchronies | Meet the expert |
13:00 - 14:00 | 628 | ME11 Asthma and sleep-disordered breathing in children and adults | Meet the expert |
13:00 - 14:00 | 629 | ME10 Effects of exercise on airway responsiveness | Meet the expert |
13:00 - 14:30 | 631 | PD9 Combining the clinic and research | Professional development workshop |
14:30 - 16:50 | 638 | SW21 Polysomnography in adults and children | Skills workshop |
14:30 - 16:50 | 639 | SW20 Radiological-pathological correlations for clinicians | Skills workshop |
14:45 - 16:45 | 640 | Respiratory infectious disease control in Europe | Session |
14:45 - 16:45 | 641 | The future of tyrosin kinase inhibitors | Symposium |
14:45 - 16:45 | 642 | Future challenges in pulmonary arterial hypertension: An ERS/ESC, and Patient Organisation PAH Europe joint symposium | Symposium |
14:45 - 16:45 | 643 | Living and dying with lung disease | Symposium |
14:45 - 16:45 | 644 | Genetics, epigenetics and the exposome | Hot topics |
14:45 - 16:45 | 645 | Transition to adult care: what we can learn from cystic fibrosis? | Symposium |
14:45 - 16:45 | 646 | Molecular phenotyping of severe asthma | Hot topics |
14:45 - 16:45 | 647 | Noninvasive ventilation versus high-flow nasal therapy for hypoxemic patients | Hot topics |
14:45 - 16:45 | 648 | Therapeutic horizons: novel targets and pharmacological models | Oral Presentation |
14:45 - 16:45 | 649 | Mechanisms of symptoms and exercise limitation in health and disease | Oral Presentation |
14:45 - 16:45 | 650 | Insights into the pathophysiology of childhood lung disease | Oral Presentation |
14:45 - 16:45 | 651 | Central sleep apnoea and the central regulation of obstructive and central sleep apneoa | Oral Presentation |
14:45 - 16:45 | 652 | IPF clinical | Oral Presentation |
14:45 - 16:00 | 653 | Becoming a successful young researcher in an era of opportunities | Session |
14:45 - 16:45 | 654 | Asthma and allergy in infancy: from risk factors to mortality | Poster Discussion |
14:45 - 16:45 | 655 | Emerging issues in smoking cessation and tobacco products | Poster Discussion |
14:45 - 16:45 | 656 | Biomarkers and phenotypes of COPD and comorbidities | Poster Discussion |
14:45 - 16:45 | 657 | Post-transplant complications: from animal models to the bedside | Poster Discussion |
14:45 - 16:45 | 658 | Mechanisms of disease | Poster Discussion |
14:45 - 16:45 | 659 | Transbronchial diagnostics: from ILD to pheripheral lesions | Poster Discussion |
15:00 - 17:00 | 660 | PD10 Writing multiple choice questions | Professional development workshop |
16:00 - 17:15 | 664 | ERS Fellowship Career Development session | Session |